TS Stratified Chemotherapy and VEGF Inhibition in Non-Squamous Non-Small Cell Lung Cancer - Stage IV
Status: Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 10 Oct 2014
Price : $35 *
At a glance
- Drugs Bevacizumab (Primary) ; Cisplatin (Primary) ; Pemetrexed (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms SELECT-A
- 31 Aug 2018 Biomarkers information updated
- 28 Sep 2013 Status changed from recruiting to withdrawn prior to recruitment as reported by European Clinical Trials Database.
- 22 Jun 2013 New source identified and integrated (European Clinical Trials Database, EudraCT2011-002145-35).